MOLECULAR-CLONING AND HETEROLOGOUS EXPRESSION OF A CDNA-ENCODING A MOUSE GLUTATHIONE-S-TRANSFERASE YC SUBUNIT POSSESSING HIGH CATALYTIC ACTIVITY FOR AFLATOXIN B1-8,9-EPOXIDE

被引:80
作者
HAYES, JD
JUDAH, DJ
NEAL, GE
NGUYEN, T
机构
[1] UNIV EDINBURGH, ROYAL INFIRM, DEPT CLIN BIOCHEM, EDINBURGH EH3 9YW, MIDLOTHIAN, SCOTLAND
[2] MRC LABS, TOXICOL UNIT, CARSHALTON SM5 4EF, SURREY, ENGLAND
关键词
D O I
10.1042/bj2850173
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resistance to the carcinogenic effects of aflatoxin B1 (AFB1) in the mouse is due to the constitutive expression of an Alpha-class glutathione S-transferase (GST), YcYc, with high detoxification activity towards AFB1-8,9-epoxide. A cDNA clone (pmusGST Yc) for a murine GST Yc polypeptide has been isolated. Sequencing has shown the cDNA insert of pmusGST Yc to be 922 bp in length, with an open reading frame of 663 bp that encodes a polypeptide of M(r) 25 358. The primary structure of the murine GST Yc subunit predicted by pmusGST Yc is in complete agreement with the partial amino acid sequence of the aflatoxin-metabolizing mouse liver GST described previously [McLellan, Kerr, Cronshaw & Hayes (1991) Biochem. J. 276, 461-469]. A plasmid, termed pKK-musGST Yc, which permits the expression of the murine Yc subunit in Escherichia coli, has been constructed. The murine GST expressed in E. coli was purified and found to be catalytically active towards several GST substrates, including AFB1-8,9-epoxide. This enzyme was also found to possess electrophoretic and immunochemical properties closely similar to those of the GST Yc subunit from mouse liver. However, the GST synthesized in E. coli and the constitutive mouse liver Alpha-class GST exhibited small differences in their chromatographic behaviour during reverse-phase h.p.l.c. Automated Edman degradation revealed alanine to be the N-terminal amino acid in the GST Yc subunit expressed in E. coli, whereas the enzyme in mouse liver possesses a blocked N-terminus. Although sequencing showed that the purified Yc subunit from E. coli lacked the initiator methionine, the amino acid sequence obtained over the first eleven N-terminal residues agreed with that predicted from the cDNA clone, pmusGST Yc. Comparison of the deduced amino acid sequence of the mouse Yc polypeptide with the primary structures of the rat Alpha-class GST enzymes revealed that it is more closely related to the ethoxyquin-induced rat liver Yc2 subunit than to the constitutively expressed rat liver Yc1 subunit. The significance of the fact that both mouse Yc and rat Yc2 exhibit high catalytic activity towards AFB1-8,9-epoxide, whereas rat Yc1 possesses little activity towards this compound, is discussed in terms of structure/function.
引用
收藏
页码:173 / 180
页数:8
相关论文
共 60 条
[1]   CYTOSOLIC GLUTATHIONE TRANSFERASES FROM RAT-LIVER - PRIMARY STRUCTURE OF CLASS-ALPHA GLUTATHIONE TRANSFERASE 8-8 AND CHARACTERIZATION OF LOW-ABUNDANCE CLASS-MU GLUTATHIONE TRANSFERASES [J].
ALIN, P ;
JENSSON, H ;
CEDERLUND, E ;
JORNVALL, H ;
MANNERVIK, B .
BIOCHEMICAL JOURNAL, 1989, 261 (02) :531-539
[2]   ATG VECTORS FOR REGULATED HIGH-LEVEL EXPRESSION OF CLONED GENES IN ESCHERICHIA-COLI [J].
AMANN, E ;
BROSIUS, J .
GENE, 1985, 40 (2-3) :183-190
[3]   THE SENSITIVITY OF RAINBOW-TROUT AND OTHER FISH TO CARCINOGENS [J].
BAILEY, GS ;
HENDRICKS, JD ;
NIXON, JE ;
PAWLOWSKI, NE .
DRUG METABOLISM REVIEWS, 1984, 15 (04) :725-750
[4]   MOUSE HEPATIC GLUTATHIONE TRANSFERASE ISOENZYMES AND THEIR DIFFERENTIAL INDUCTION BY ANTICARCINOGENS - SPECIFICITIES OF BUTYLATED HYDROXYANISOLE AND BISETHYLXANTHOGEN AS INDUCERS OF GLUTATHIONE TRANSFERASES IN MALE AND FEMALE CD-1 MICE [J].
BENSON, AM ;
HUNKELER, MJ ;
YORK, JL .
BIOCHEMICAL JOURNAL, 1989, 261 (03) :1023-1029
[5]   SCREENING GAMMAGT RECOMBINANT CLONES BY HYBRIDIZATION TO SINGLE PLAQUES INSITU [J].
BENTON, WD ;
DAVIS, RW .
SCIENCE, 1977, 196 (4286) :180-182
[6]   EXPRESSION OF HUMAN GLUTATHIONE S-TRANSFERASES IN SACCHAROMYCES-CEREVISIAE CONFERS RESISTANCE TO THE ANTICANCER DRUGS ADRIAMYCIN AND CHLORAMBUCIL [J].
BLACK, SM ;
BEGGS, JD ;
HAYES, JD ;
BARTOSZEK, A ;
MURAMATSU, M ;
SAKAI, M ;
WOLF, CR .
BIOCHEMICAL JOURNAL, 1990, 268 (02) :309-315
[7]  
BOLTON MG, 1991, CANCER RES, V51, P2410
[8]  
BUETLER TM, 1992, CANCER RES, V52, P314
[9]  
BULLER AL, 1987, MOL PHARMACOL, V31, P575
[10]  
CAMPBELL TC, 1990, CANCER RES, V50, P6882